Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingredion (INGR) Notes Payables (2016 - 2022)

Ingredion's Notes Payables history spans 7 years, with the latest figure at $622.0 million for Q3 2022.

  • For Q3 2022, Notes Payables rose 1195.83% year-over-year to $622.0 million; the TTM value through Sep 2022 reached $622.0 million, up 1195.83%, while the annual FY2021 figure was $250.0 million, 331.03% up from the prior year.
  • Notes Payables reached $622.0 million in Q3 2022 per INGR's latest filing, up from $558.0 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $622.0 million in Q3 2022 to a low of $48.0 million in Q3 2021.
  • Average Notes Payables over 5 years is $160.3 million, with a median of $96.5 million recorded in 2019.
  • Peak YoY movement for Notes Payables: crashed 51.48% in 2019, then surged 1195.83% in 2022.
  • A 5-year view of Notes Payables shows it stood at $169.0 million in 2018, then plummeted by 51.48% to $82.0 million in 2019, then dropped by 29.27% to $58.0 million in 2020, then soared by 331.03% to $250.0 million in 2021, then soared by 148.8% to $622.0 million in 2022.
  • Per Business Quant, the three most recent readings for INGR's Notes Payables are $622.0 million (Q3 2022), $558.0 million (Q2 2022), and $86.0 million (Q1 2022).